Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur

Ketamine

Brief Summary

Proximal femur fractures are one of the commonest fractures especially in the elderly population. Early surgical fixation is the best analgesic for associated pain. Spinal anesthesia has been favored by many anesthesiologists due to the simplicity of the technique, the better analgesic profile, and the lower incidence of complications like delirium and thromboembolic events. However, severe pain, encountered during positioning for spinal anesthesia, can complicate the technique and worsen the patient experience. the study aim to compare the analgesic effect of intravenous dexmedetomidine and fascia iliaca block preoperatively to assist positioning patients for performance of spinal anesthesia.

Intervention / Treatment

  • ultrasound guided facia iliaca block (DEVICE)
    Patient will received ultrasound guided fascia iliaca block by 20 ml Bupivacaine 0,25% .
  • Intravenous drug (DRUG)
    Patient will received intravenous injection of precedex 0.25mic/Kg and ketamine 0,2 mg/kg .

Condition or Disease

  • Pain
  • Analgesia

Phase

  • Not Applicable

    • Study Design

    Study type: INTERVENTIONAL
    Status: Recruiting
    Study results: No Results Available
    Age: 18 Years to 60 Years
    Enrollment: 70 (ESTIMATED)
    Allocation: Randomized
    Primary Purpose: Prevention

    Masking

    DOUBLE:
    • Participant
    • Investigator

    Clinical Trial Dates

    Start date: Feb 11, 2023 ACTUAL
    Primary Completion: Aug 01, 2023 ESTIMATED
    Completion Date: Sep 01, 2023 ESTIMATED
    Study First Posted: Jan 31, 2023 ACTUAL
    Last Updated: Mar 13, 2023

    Sponsors / Collaborators

    Lead Sponsor: Minia University
    Responsible Party: N/A

    Participant Groups

    • No description provided

    • No description provided

    Eligibility Criteria

    Sex: All
    Minimum Age: 18
    Maximum Age: 60
    Age Groups: Adult
    Healthy Volunteers: Yes

    Inclusion Criteria:

    1. Aged 18-60 years.
    2. Hip fractures
    3. Both sexes.

    Exclusion Criteria:

    1. Patient refusal
    2. Allergy to local anesthetics
    3. Bleeding diathesis or history of anticoagulant use.
    4. impaired cognition or dementia
    5. . Infection of the skin at the site of needle punctures area
    6. multiple fractures
    7. Any previous analgesic administration during the last 12 hours

    This clinical trial is recruiting

    Are you interested in participating in this trial or others? We'd love to help.

    Primary Outcomes

    • 0 = calm, 1 = facial grimacing, 2 = moaning, 3 = screaming, and 4 = unable to proceed because of restlessness or agitation

    Secondary Outcomes

    • 0 = poor hip flexion, 1 = satisfactory hip flexion, 2 = good hip flexion, and 3 = optimal hip flexion

    More Details

    NCT Number: NCT05705726
    Other IDs: 524/2022
    Study URL: https://clinicaltrials.gov/study/NCT05705726
    Last updated: Sep 29, 2023